The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of pembrolizumab for HPV-associated papilloma patients with laryngeal, tracheal, and/or pulmonary involvement.
 
Sara I. Pai
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; CUE Biopharma; Merck; Newlink Genetics/Pharmatech
Research Funding - Abbvie; AstraZeneca/MedImmune (Inst); CUE Biopharma; Merck (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca/MedImmune; Merck
 
Aaron D Friedman
No Relationships to Disclose
 
Ramon Franco
Stock and Other Ownership Interests - Interscope Medical
Patents, Royalties, Other Intellectual Property - Interscope Medical
 
Ashok Muniappan
No Relationships to Disclose
 
Jong Chul Park
No Relationships to Disclose
 
Nicholas Paul Campbell
No Relationships to Disclose
 
Seth B. Krantz
No Relationships to Disclose
 
Phillip C Song
No Relationships to Disclose
 
Michiel Bove
No Relationships to Disclose
 
Thomas L Carroll
Stock and Other Ownership Interests - Sofregen
Consulting or Advisory Role - Pentax Medical Devices
Patents, Royalties, Other Intellectual Property - Share Patent on Device with Sofregen Medical
Travel, Accommodations, Expenses - Sofregen
 
William C Faquin
No Relationships to Disclose
 
Anne M. O'Neill
No Relationships to Disclose
 
Lori J. Wirth
Consulting or Advisory Role - Amgen; Ayala Pharmaceuticals; Blueprint Medicines; CUE Biopharma; Eisai; Loxo; Merck; Novartis
Other Relationship - Iovance Biotherapeutics